February 23, 2024

Dutch Parliamentarians Want Large-Scale Study into Ongoing Excess Mortality Rates

Many members of the Tweede Kamer, the lower house of the Dutch Parliament, want a large-scale cohesive study to be carried out into the causes of excess mortality in the Netherlands since 2020. More people have died than expected for four years in a row.
February 23, 2024

Test Screening For 11 Blood Biomarkers Could Predict Dementia 15 Years Sooner

A new study from scientists at The University of Warwick in the United Kingdom and Fudan University in China has identified 11 proteins that can be used as biomarkers to predict dementia 15 years before diagnosis.
February 23, 2024

Huge Delays In Dealing With Complaints Against UK Drug Companies Revealed

Processing times for complaints against drug companies suspected of having breached their industry code of practice have more than tripled in a nearly two-decade period, an investigation by The BMJ has found.
February 23, 2024

Study Links Higher Omega-3 Levels to Decreased Stroke Risk

A new study published in the journal Stroke shows that people with the highest omega-3 levels have a lower risk of stroke.
February 16, 2024

Green Tea Could Reduce Risk of Dementia

A study conducted at the University of Leeds in the UK has concluded that drinking green tea on a regular basis can not only improve your brain power, but also lower your chances of getting dementia later on in life. This is due to a chemical compound found exclusively in green tea.
February 16, 2024

Raft of Legal Challenges Launched Against EU Reauthorization of Glyphosate

The European Commission’s decision to reauthorize the herbicide glyphosate for 10 years is being challenged in three separate legal actions.
February 16, 2024

Southern Africa’s Cholera Outbreak is a Multinational Fight

A cholera crisis has engulfed southern Africa. As cases surge across Zambia, Zimbabwe, Malawi, Mozambique and the Democratic Republic of the Congo, a lack of clean water and sanitation continue to threaten lives.
February 16, 2024

Big Pharma Spends Billions More on Executives and Stockholders Than on Research and Development

A United States Senate report points to greed and "patent thickets" as the key reasons for high drug prices.